MARKET NEWS

Timber Pharmaceuticals Reports Positive Top-Line Results from Phase 2b CONTROL Study Evaluating TMB-001 in Moderate-to-Severe Congenital Ichthyosis
Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals, Strengthening its CNS Product Portfolio
Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management
Fortress Biotech Announces Closing of Acquisition of Caelum Biosciences by AstraZeneca
Acumen Announces First Patient Dosed in a Phase 1 Clinical Trial of Monoclonal Antibody 
Albireo Announces Exclusive Licensing Agreement With Jadeite Medicines 

  FEATURED EDITORIAL

 

  COMPANY PROFILE

Micropore Technologies is a global process technology and service provider to the pharmaceutical industry featuring patented membrane emulsification equipment for the commercially scalable development of microspheres, nanoparticles, and emulsions used in a wide range of controlled release, sterile injectable drug products. Originally spun-out of Loughborough University’s internationally renowned chemical engineering department, the company’s global headquarters and technical center are located in Wilton Center, UK with offices and operations in the USA, India, South Korea & Japan supporting over a hundred clients and strategic partners. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Pace Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

Pace Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

Pace Analytical Life Sciences, LLC, a subsidiary of Pace Analytical Services, LLC, a full-service contract development and manufacturing organization (CDMO), recently announced that it has acquired Velesco….

Centogene & Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases

Centogene & Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases

Centogene N.V. and Twist Bioscience Corporation recently announced they have signed a contract to collaborate on the development and commercialization of custom assay kits for rare diseases…..

Acer Therapeutics & Relief Therapeutics Announce FDA Acceptance for Filing of NDA

Acer Therapeutics & Relief Therapeutics Announce FDA Acceptance for Filing of NDA

Acer Therapeutics Inc. and its collaboration partner, Relief Therapeutics Holding SA recently announced the US FDA has accepted for filing the New Drug Application (NDA) for ACER-001 (sodium phenylbutyrate) for the….

Agenus to Receive -Million Milestone Payment From Bristol Myers Squibb With Dosing of First Patient 

Agenus to Receive $20-Million Milestone Payment From Bristol Myers Squibb With Dosing of First Patient 

Agenus Inc. recently announced it has triggered the first development milestone payment under its global licensing agreement with Bristol Myers Squibb for AGEN1777, an Fc-enhanced bispecific….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

October 27 – Analytical Testing
November 3 – Formulation Development